Medicine & TechnologyHealthcare researchers and doctors from Johns Hopkins University have developed a liquid biopsy through blood test that has a screening tool to detect cancer. This provides an opportunity for a minimally-invasive oncology test to reduce morbidity and mortality from cancer.
A U.S. medical company reveals it is launching the "holy grail" of blood tests that can diagnose cancer even before patients have manifested its symptoms through liquid biopsy.